Cargando…

Nonalcoholic fatty liver disease impacts the control of the international normalized ratio in patients with atrial fibrillation

BACKGROUND: It is unclear whether the therapeutic effect of warfarin in patients with atrial fibrillation (AF) and normal liver function differs between those with and without nonalcoholic fatty liver disease (NAFLD). With this in mind, we aimed to evaluate the impact of NAFLD on the international n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xi, Chen, Guang-Yu, Wang, Zhao-Xia, Li, Xue-Hai, Luo, Rong, Li, Yi-Gang, Yang, Fan, Zhou, Xin, Jiang, Feng, Wang, Yao-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475506/ https://www.ncbi.nlm.nih.gov/pubmed/32953808 http://dx.doi.org/10.21037/atm-20-5387

Ejemplares similares

Prognostic Value of International Normalized Ratio in Ischemic Stroke Patients without Atrial Fibrillation or Anticoagulation Therapy
por: Xie, Xuewei, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease as a predictor of atrial fibrillation: a systematic review and meta-analysis
por: Zhou, Yaqiong, et al.
Publicado: (2017)

Nonalcoholic fatty liver disease and atrial fibrillation: possible pathophysiological links and therapeutic interventions
por: Haghbin, Hossein, et al.
Publicado: (2020)

International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
por: Nelson, Winnie W., et al.
Publicado: (2015)

Achieving target international normalization ratio in haemodialysis patients with atrial fibrillation: is it feasible?
por: Tsagalis, Georgios, et al.
Publicado: (2011)

Identification of genes and key pathways underlying the pathophysiological association between nonalcoholic fatty liver disease and atrial fibrillation
por: Chu, Yanan, et al.
Publicado: (2022)

Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban
por: Chao, Tze-Fan, et al.
Publicado: (2022)

Association of blood pressure level with nonalcoholic fatty liver disease in nonhypertensive population: Normal is not the new normal
por: Qian, Lin-Yan, et al.
Publicado: (2016)

Association between the platelet/high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: results from NHANES 2017–2020
por: Lu, Chun-feng, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Is Associated with Increased Atrial Fibrillation Risk in an Elderly Chinese Population: A Cross-Sectional Study
por: Zhang, Yu, et al.
Publicado: (2018)

Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targets
por: Ding, Ya-Hui, et al.
Publicado: (2017)

Update on Berberine in Nonalcoholic Fatty Liver Disease
por: Liu, Yang, et al.
Publicado: (2013)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Risk factors for ischemic stroke in patients with non-valvular atrial fibrillation and therapeutic international normalized ratio range
por: Wańkowicz, Paweł, et al.
Publicado: (2018)

Clinical value of thyroid related hormones combined with neutrophil to lymphocyte ratio in patients with nonalcoholic fatty liver disease
por: Li, Ping, et al.
Publicado: (2022)

Obesity and nonalcoholic fatty liver disease associated with adenocarcinoma in patients with lung cancer
por: Zhu, Chan-Yan, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study
por: Lee, So-Ryoung, et al.
Publicado: (2021)

Bibliometric analysis of top 100 cited articles in nonalcoholic fatty liver disease research
por: Zhang, Tong-Shuo, et al.
Publicado: (2016)

The Association of Nonalcoholic Fatty Liver Disease With Neutrophil-to-Lymphocyte Ratio and Neutrophil-Percentage-to-Albumin Ratio
por: Cucoranu, Dragoș Constantin, et al.
Publicado: (2023)

Increased Levels of Systolic Blood Pressure Within the Normal Range Are Associated With Significantly Elevated Risks of Nonalcoholic Fatty Liver Disease
por: Wu, Sheng-Jie, et al.
Publicado: (2015)

Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
por: Lu, Wenxia, et al.
Publicado: (2016)

The Relationship between Normal Serum Uric Acid and Nonalcoholic Fatty Liver Disease
por: Hwang, In-Cheol, et al.
Publicado: (2011)

Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease
por: Zhao, Yanhua, et al.
Publicado: (2022)

Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study
por: Ren, Xiao Yu, et al.
Publicado: (2019)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022)

Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux
por: Liu, Cong, et al.
Publicado: (2018)

Low Bone Mineral Density in Chinese Adults with Nonalcoholic Fatty Liver Disease
por: Cui, Ran, et al.
Publicado: (2013)

Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic review
por: Zhang, Tong-shuo, et al.
Publicado: (2015)

Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
por: Jung, Chan-Hee, et al.
Publicado: (2020)

PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease
por: Wang, Jin-Zhi, et al.
Publicado: (2018)

The correlation between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with nonalcoholic fatty liver disease: a cross-sectional study
por: Zhou, Yuge, et al.
Publicado: (2022)

Pathogenesis of and major animal models used for nonalcoholic fatty liver disease
por: Jiang, Mingzuo, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
por: Zhang, Rui-Nan, et al.
Publicado: (2021)

Association between the Triglyceride–Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation
por: Li, Xiaozhong, et al.
Publicado: (2023)

Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese
por: Huang, Xiaolin, et al.
Publicado: (2015)

The Impact of Weight Changes on Nonalcoholic Fatty Liver Disease in Adult Men with Normal Weight
por: Cho, Ji-Young, et al.
Publicado: (2014)

Comparison of platelet number and function between nonalcoholic fatty liver disease and normal individuals
por: Saremi, Zeinab, et al.
Publicado: (2017)

Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
por: Yan, Tingting, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3fg9rk1ptb277h6k3u7egok32i